Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:dateCreated |
1986-10-30
|
pubmed:abstractText |
The effects of the cerebral calcium antagonist flunarizine in 50 geriatric patients with light brainorganic psychosyndrome were determined in the course of a 12 weeks' placebo-controlled pharmacopsychological double-blind study. Factor analysis on the basis of 19 individual psychological tests served as multivariate evaluation model. Advantages of flunarizine became evident in factors 1 (contentedness), 3 (alertness) and 4 (good memory/sound sleep). The increased performance (factor 2) in both groups may well be due to a training effect and would, therefore, be artificial.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:issn |
0014-3022
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
25 Suppl 1
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
115-21
|
pubmed:dateRevised |
2007-11-15
|
pubmed:meshHeading |
pubmed-meshheading:3530773-Aged,
pubmed-meshheading:3530773-Aged, 80 and over,
pubmed-meshheading:3530773-Clinical Trials as Topic,
pubmed-meshheading:3530773-Delirium, Dementia, Amnestic, Cognitive Disorders,
pubmed-meshheading:3530773-Double-Blind Method,
pubmed-meshheading:3530773-Factor Analysis, Statistical,
pubmed-meshheading:3530773-Female,
pubmed-meshheading:3530773-Flunarizine,
pubmed-meshheading:3530773-Follow-Up Studies,
pubmed-meshheading:3530773-Humans,
pubmed-meshheading:3530773-Male,
pubmed-meshheading:3530773-Middle Aged
|
pubmed:year |
1986
|
pubmed:articleTitle |
Pharmacopsychological effects of flunarizine in geriatric patients with light brainorganic psychosyndrome. Preliminary communication.
|
pubmed:publicationType |
Journal Article,
Clinical Trial,
Controlled Clinical Trial
|